Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Minoryx Therapeutics and Sperogenix Therapeutics enter into an exclusive license agreement to develop and commercialize leriglitazone in mainland China, Hong Kong and Macau 2020-09-23 15:00
Alcohol Detection Anklets Showing Promise in NZ 2020-09-22 04:24
China Pharmaceutical Holdings Co., Ltd. Has Obtained Multiple Certifications for Its Masks 2020-09-21 20:30
I-Mab Announces China NMPA Clearance for Phase 1 Clinical Trial of Lemzoparlimab in Relapsed or Refractory Advanced Lymphoma 2020-09-21 20:00
PharmAbcine expands partnership with Samsung Biologics for PMC-403 2020-09-21 20:00
WellsCare signs in-store contract with b8ta for IASO 2020-09-20 20:00
Preparation products of Yiling Pharma approved by FDA for launch in the US market 2020-09-19 19:14
MorphoSys and I-Mab Announce FDA Clearance of IND Application for MOR210/TJ210 in Patients with Advanced Cancer 2020-09-18 04:05
Dr. Steven Yu Joins ChemPartner as Vice President of Regulated Bioanalysis 2020-09-17 23:01
Expanding Their Existing Strategic Collaboration, GenScript ProBio Licensed Global Rights to Develop and Commercialize a SMAB Bispecific Antibody Molecule to REMD Biotherapeutics Inc. 2020-09-17 22:00
Samsung Biologics signs development agreement with Panolos for solid tumor treatment 2020-09-17 08:43
Transcenta Successfully Scaled up the Continuous Perfusion Process and Completed GMP Manufacturing of a Novel Bispecific Antibody for Cancer Immunotherapy 2020-09-15 23:00
Verkada Introduces Environmental Sensor to Provide Enhanced Visibility into Physical Spaces 2020-09-15 21:40
PharmAbcine Unveils Olinvacimab's Positive Results from Phase Ib Combination Studies at KSMO 2020 2020-09-14 20:00
Coronavirus Breakthrough: Senhwa Reports First eIND Silmitasertib Treated Severe COVID-19 Patient - Discharged Following Five Days of Treatment 2020-09-12 08:34
NaviFUS Launches Neuronavigation-guided Clinical Trial to Open the Blood-Brain-Barrier for Combination FUS-Bevacizumab Therapy in rGBM Patients 2020-09-11 20:55
Tottenham Acquisition I Limited Announces Filing of a Registration Statement on Form S-4 in Connection with its Proposed Business Combination with Clene Nanomedicine, Inc. 2020-09-10 20:56
CMAB Biopharma and Laekna Therapeutics Enter Strategic Agreement for LAE005 Global Development and Commercialization Partnership 2020-09-10 20:08
The Global Clinical CRO Fountain Medical Development and its Affiliates Rebrand as ClinChoice Inc 2020-09-10 09:00
Clarity Pharmaceuticals Announces the US FDA Grants Rare Paediatric Disease Designation to 64Cu-SARTATE™, a diagnostic for the clinical management of neuroblastoma 2020-09-09 21:13
1 202 203 204 205 206 440